Fay Nugent
Head of Operations
Fay Nugent is Head of Operations for the Draper Group at the University of Oxford. She oversees grants management, finance, human resources, and the operational delivery of the group's research programmes.
Having previously worked as a Preclinical Project Manager, Clinical Project Manager, and Clinical Programme Manager within the group, Fay brings extensive experience across the research and clinical development pathway. Her broad understanding of both scientific and operational processes helps support the successful delivery of the group's vaccine research portfolio.
Recent publications
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.
Journal article
Hou MM. et al, (2025), Nat Commun, 16
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.
Journal article
Silk SE. et al, (2024), Lancet Infect Dis, 24, 1105 - 1117
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.
Journal article
Silk SE. et al, (2023), Med, 4, 668 - 686.e7
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Journal article
Hou MM. et al, (2023), Sci Transl Med, 15
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.
Journal article
Salkeld J. et al, (2022), Front Immunol, 13